Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment

Autor: Marjan Ghiti Moghadam, Femke B. G. Lamers-Karnebeek, Harald E. Vonkeman, Peter M. ten Klooster, Janneke Tekstra, Barbara van Schaeybroeck, Ruth Klaasen, Marieke van Onna, Hein J. Bernelot Moens, Henk Visser, Annemarie M. Schilder, Marc R. Kok, Robert B. M. Landewé, Piet L. C. M. van Riel, Mart A. F. J. van de Laar, Tim L. Jansen, on behalf of the Dutch National POET Collaboration

Publikováno v: BMC Rheumatology, Vol 3, Iss 1, Pp 1-8 (2019)

Abstract Background The aim of this study was to identify predictors of prolonged disease control after discontinuation of tumor necrosis factor inhibitor (TNFi) treatment in patients with rheumatoid arthritis (RA). Methods Post-hoc analysis of 439 R

Externí odkaz: https://doaj.org/article/ddbedcb42a224131ae7c3a0b9702e2e3

AB0160 HIGH NUMBER OF CONCOMITANT MEDICATIONS AND COMORBIDITIES AT BASELINE IN THE GLUCOCORTICOID LOW-DOSE OUTCOME IN RHEUMATOID ARTHRITIS (GLORIA) STUDY: AN OLDER POPULATION WITH RHEUMATOID ARTHRITIS

Autor: Paul Baudoin, Zoltán Szekanecz, R. Bos, H G Raterman, L. Hartman, Cornelia F Allaart, E. N. Griep, Daniela Opris-Belinski, Ruth Klaasen, Annemarie M. Schilder, Frank Buttgereit, Sabrina Paolino, Marc R. Kok, Maarten Boers, W.F. (Willem) Lems, Thomas Klausch, P. Masaryk, J. A. P. Da Silva, M. Cutolo

Publikováno v: Annals of the Rheumatic Diseases. 80:1107.1-1107

Background:Treatment with low-dose glucocorticoids (GCs) (≤7.5 mg prednisolone) in combination with standard care is highly effective in rheumatoid arthritis (RA), but despite 70 years of clinical experience, evidence-based information on its balan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c39b0e8ba6d32f90401a9c079d16dc11
https://doi.org/10.1136/annrheumdis-2021-eular.2013

Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment

Autor: Willem F. Lems, Henk Visser, Piet L. C. M. van Riel, Marjan Ghiti Moghadam, Dirk Jan Van Schaardenburg, Eric H. Sasso, Harald E. Vonkeman, Annemarie M. Schilder, Mart A F J van de Laar, Peter M. ten Klooster, Femke B. G. Lamers-Karnebeek, Janneke Tekstra, Robert Landewé, T.L.Th.A. Jansen, David Chernoff, Timothy R D J Radstake, Hein J. Bernelot Moens

Publikováno v: on behalf of the Dutch National POET Collaboration 2018, ' Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment ', PLoS ONE, vol. 13, no. 5, e0192425 . https://doi.org/10.1371/journal.pone.0192425
PLoS ONE [E], 13(5). Public Library of Science
PLoS ONE, 13(5):e0192425. Public Library of Science
PLoS ONE
PLoS One, 13, 5
PLoS One, 13
PLoS ONE, Vol 13, Iss 5, p e0192425 (2018)

Objective Successfully stopping or reducing treatment for patients with rheumatoid arthritis (RA) in low disease activity (LDA) may improve cost-effectiveness of care. We evaluated the multi-biomarker disease activity (MBDA) score as a predictor of d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33894034e91d3de5e5b610dd849b64d8
https://research.vumc.nl/en/publications/45c10ad2-3ce2-498d-83ae-1096281a0bc5

Ascites as the presenting symptom in a patient with Churg-Strauss syndrome

Autor: Aaltje Y, Adema, Annemarie M, Schilder, Tim C M A, Schreuder, Karin, Grünberg, Irine E M, Bultink, Chris J J, Mulder

Publikováno v: Journal of gastrointestinal and liver diseases : JGLD. 19(2)

A 67-year-old male presented with ascites, dyspnoea, peripheral edema and purpura. The history revealed asthma and nasal polyps. The laboratory tests showed an increased peripheral blood eosinophilic cell count. The ascitic fluid analysis showed feat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0b5e8573b5a2eb08595377c6f354d223
https://pubmed.ncbi.nlm.nih.gov/20593056